Latest Security News

Connected Minerals Ltd has successfully raised $5.1 million to fuel its aggressive uranium exploration in Namibia, reporting impressive high-grade rock chip results that set the stage for maiden drilling in early 2025.

Peregrine Gold secures a significant $1 million commitment from its largest shareholder, Yandal Investments, strengthening its entitlement offer ahead of the project sale to Capricorn Metals.

Peregrine Gold Limited has updated its prospectus to reveal a significant increase in share commitments from its largest shareholder, Yandal Investments, alongside key directors’ participation in the capital raise.

Discovery Alaska Limited is actively assessing new project opportunities and reviewing strategies for its key Alaskan gold assets, while maintaining cautious financial management with limited cash reserves.

Australian Rare Earths Limited has secured a $5 million government grant to advance its Koppamurra Rare Earths Project, while initial drilling at its Overland Uranium Project validates promising geological models for uranium deposits.

Falcon Metals reports steady progress across its Victorian and Western Australian projects, maintaining a strong cash position to fuel ongoing exploration in 2025.

Neometals Ltd has bolstered its financial position with a A$7.1 million capital raise while progressing key projects including the commissioning of a lithium-ion battery recycling plant in Germany and preparing for maiden gold drilling at Barrambie.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.

Cardiex Limited has commenced U.S. deliveries of its CONNEQT Pulse arterial health monitor alongside the launch of its companion CONNEQT App, marking a pivotal expansion into the American digital health market.

Nyrada Inc. reports promising preclinical results for its lead drug NYR-BI03, showing an 86% cardioprotective effect, alongside a strong financial position bolstered by a AU$3.29 million capital raise. The company has submitted its Phase Ia clinical trial package, setting the stage for human testing.

Universal Biosensors has secured a Vendor Master Purchase Agreement with Chewy and launched its Petrackr veterinary glucose monitoring system on Amazon, positioning itself for significant growth in North America's online pet care market.